Allegro secures financing for clinical trial preparations in osteoarthritis
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 3 […]
Tag: Osteoarthritis
Allegro demonstrates safety profile of osteoarthritis hydrogel in data presentation at World Congress on Osteoporosis
Liege, Belgium – 11 April 2025 (17:00 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for osteoarthritis, today presented […]
Allegro’s injectable osteoarthritis device generates positive safety results in preclinical studies
Liege, Belgium – 25 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based devices for osteoarthritis, has found […]
Allegro reports positive safety data for its injectable osteoarthritis device in three preclinical studies
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 4 […]
Allegro’s osteoarthritis injectable shock absorbing device demonstrates preclinical safety
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 11 […]